Literature DB >> 18165258

Targets of tyrosine nitration in diabetic rat retina.

Xianquan Zhan1, Yunpeng Du, John S Crabb, Xiaorong Gu, Timothy S Kern, John W Crabb.   

Abstract

Diabetic retinopathy, a retinal vascular disease, is inhibited in animals treated with aminoguanidine, an inhibitor of inducible nitric-oxide synthase. This treatment also reduces retinal protein nitration, which is greater in diabetic rat retina than nondiabetic retina. As an approach to understanding the molecular mechanisms of diabetic retinopathy, we sought the identity of nitrotyrosine-containing proteins in retina from streptozotocin-induced diabetic rats and in a rat retinal Müller cell line grown in high glucose (25 mM). Anti-nitrotyrosine immunoprecipitation products from rat retina and Müller cells were analyzed by LC-MS/MS. Ten nitrated proteins in diabetic rat retina and three nitrated proteins in Müller cells grown in high glucose were identified; three additional nitrotyrosine-containing proteins were tentatively identified from diabetic retina. The identified nitrotyrosine-containing proteins participate in a variety of processes including glucose metabolism, signal transduction, and transcription/translation. Among the nitrated proteins were insulin-responsive glucose transporter type 4 (GLUT-4), which has been implicated previously in the pathogenesis of diabetes mellitus; exocyst complex component Exo70, which functions in insulin-stimulated glucose uptake of GLUT-4-containing vesicles; and fibroblast growth factor receptor 2, which influences retinal vascularization via fibroblast growth factor signaling. Nitration of tyrosine phosphorylation sites were identified in five proteins, including GLUT-4, exocyst complex component Exo70, protein-tyrosine phosphatase eta, sensory neuron synuclein, and inositol trisphosphate receptor 3. Quantitation of nitration and phosphorylation at common tyrosine modification sites in GLUT-4 and protein-tyrosine phosphatase eta from diabetic and nondiabetic animals suggests that nitration reduced tyrosine phosphorylation approximately 2X in these proteins from diabetic retina. The present results provide new insights regarding tyrosine nitration and its potential role in the molecular mechanisms of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165258      PMCID: PMC2401337          DOI: 10.1074/mcp.M700417-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  49 in total

Review 1.  All in the family: the BTB/POZ, KRAB, and SCAN domains.

Authors:  T Collins; J R Stone; A J Williams
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Authors:  John W Crabb; Masaru Miyagi; Xiaorong Gu; Karen Shadrach; Karen A West; Hirokazu Sakaguchi; Motohiro Kamei; Azeem Hasan; Lin Yan; Mary E Rayborn; Robert G Salomon; Joe G Hollyfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

3.  Na+ channel Nav1.9: in search of a gating mechanism.

Authors:  Patrick Delmas; Bertrand Coste
Journal:  Trends Neurosci       Date:  2003-02       Impact factor: 13.837

Review 4.  Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies.

Authors:  B Halliwell; K Zhao; M Whiteman
Journal:  Free Radic Res       Date:  1999-12

5.  Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat.

Authors:  E Ann Ellis; Dennis L Guberski; Brenda Hutson; Maria B Grant
Journal:  Nitric Oxide       Date:  2002-05       Impact factor: 4.427

6.  Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.

Authors:  T S Kern; R L Engerman
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

7.  NoRC--a novel member of mammalian ISWI-containing chromatin remodeling machines.

Authors:  R Strohner; A Nemeth; P Jansa; U Hofmann-Rohrer; R Santoro; G Längst; I Grummt
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

8.  Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine.

Authors:  Yunpeng Du; Mark A Smith; Casey M Miller; T S Kern
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

9.  Evidence that light modulates protein nitration in rat retina.

Authors:  Masaru Miyagi; Hirokazu Sakaguchi; Ruth M Darrow; Lin Yan; Karen A West; Kulwant S Aulak; Dennis J Stuehr; Joe G Hollyfield; Daniel T Organisciak; John W Crabb
Journal:  Mol Cell Proteomics       Date:  2002-04       Impact factor: 5.911

10.  The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.

Authors:  Mark P Sowden; Nazzareno Ballatori; Karen L de Mesy Jensen; Lakesha Hamilton Reed; Harold C Smith
Journal:  J Cell Sci       Date:  2002-03-01       Impact factor: 5.285

View more
  19 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

2.  Nitroproteins Identified in Human Ex-smoker Bronchoalveolar Lavage Fluid.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  Aging Dis       Date:  2010-11-08       Impact factor: 6.745

3.  Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells.

Authors:  Rooban B Nahomi; Allison Palmer; Katelyn M Green; Patrice E Fort; Ram H Nagaraj
Journal:  Biochim Biophys Acta       Date:  2013-11-16

4.  Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected].

Authors:  M M H Al-Gayyar; S Matragoon; B A Pillai; T K Ali; M A Abdelsaid; A B El-Remessy
Journal:  Diabetologia       Date:  2010-12-07       Impact factor: 10.122

Review 5.  New focus on alpha-crystallins in retinal neurodegenerative diseases.

Authors:  Patrice E Fort; Kirsten J Lampi
Journal:  Exp Eye Res       Date:  2010-11-27       Impact factor: 3.467

6.  Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes.

Authors:  Xianglin Yuan; Xiaorong Gu; John S Crabb; Xiuzhen Yue; Karen Shadrach; Joe G Hollyfield; John W Crabb
Journal:  Mol Cell Proteomics       Date:  2010-02-22       Impact factor: 5.911

7.  Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes.

Authors:  A B El-Remessy; Y Khalifa; S Ola; A S Ibrahim; G I Liou
Journal:  Mol Vis       Date:  2010-08-04       Impact factor: 2.367

8.  The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulin.

Authors:  Patrice E Fort; Willard M Freeman; Mandy K Losiewicz; Ravi S J Singh; Thomas W Gardner
Journal:  Mol Cell Proteomics       Date:  2008-12-01       Impact factor: 5.911

9.  Glucose-modulated tyrosine nitration in beta cells: targets and consequences.

Authors:  Thomas Koeck; John A Corbett; John W Crabb; Dennis J Stuehr; Kulwant S Aulak
Journal:  Arch Biochem Biophys       Date:  2009-04-15       Impact factor: 4.013

10.  Glucose-mediated tyrosine nitration in adipocytes: targets and consequences.

Authors:  Thomas Koeck; Belinda Willard; John W Crabb; Mike Kinter; Dennis J Stuehr; Kulwant S Aulak
Journal:  Free Radic Biol Med       Date:  2008-12-24       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.